A detailed history of American Capital Advisory, LLC transactions in Amgen Inc stock. As of the latest transaction made, American Capital Advisory, LLC holds 870 shares of AMGN stock, worth $297,287. This represents 0.11% of its overall portfolio holdings.

Number of Shares
870
Previous 875 0.57%
Holding current value
$297,287
Previous $244 Million 0.49%
% of portfolio
0.11%
Previous 0.12%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 28, 2025

SELL
$271.18 - $309.22 $1,355 - $1,546
-5 Reduced 0.57%
870 $246 Million
Q2 2025

Aug 05, 2025

BUY
$262.28 - $309.85 $1,835 - $2,168
7 Added 0.81%
875 $244 Million
Q1 2025

Apr 28, 2025

BUY
$258.59 - $327.36 $14,222 - $18,004
55 Added 6.77%
868 $270 Million
Q4 2023

Apr 09, 2024

BUY
$255.7 - $288.46 $207,884 - $234,517
813 New
813 $234 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $183B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track American Capital Advisory, LLC Portfolio

Follow American Capital Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Capital Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on American Capital Advisory, LLC with notifications on news.